Read PPD’s new white paper, CV Outcomes: Evolution of the Clinical Trial Process, for key insight to help you overcome challenges and stay ahead of trends in cardiovascular outcomes research.
In this paper, PPD’s experts discuss:
- Key events and regulatory guidance influencing recent FDA regulations requiring CV outcomes evaluations for non-cardiovascular therapies
- Current considerations surrounding study endpoint definition and the endpoint adjudication process
- Global regulatory trends
- The influence of advancing technology and emerging global economies on the future of CV outcomes research
For more information about PPD, please contact us at ppdinfo@ppdi.com or +1 877 643 8773.